Flower City Capital »

Outlook Therapeutics shares owned by Flower City Capital

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Flower City Capital from 13F filings

Historical chart of Flower City Capital investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Flower City Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Flower City Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $21k 20k 1.06

More positions owned by Flower City Capital

Vanguard Scottsdale Fds Vng Rus1000idx (VONE)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Intl Equity Index F Ftse Smcap Etf (VSS)
Ishares Tr Msci Eafe Etf (EFA)
Apple (AAPL)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Admiral Fds Smllcp 600 Idx (VIOO)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
NVIDIA Corporation (NVDA)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)

View all positions for Flower City Capital

Top funds holding Outlook Therapeutics

Vanguard Group
Schonfeld Strategic Advisors
Morgan Stanley
BlackRock
Geode Capital Management
Susquehanna International
Millennium Management
Commonwealth Equity Services
Simplex Trading
State Street Corporation
Scotia Capital
LVW Advisors
UBS Group
Citadel Advisors
Goldman Sachs Group

View all funds holding Outlook Therapeutics